NMR spectroscopy
NMR data were recorded on a Bruker AVANCE III 500 MHz spectrometer.
Acetonitrile-d was used for
1 H NMR to characterize the FA-conjugated PEG. NMR data were processed using Topspin 3.0.
The molecular weight of FA-conjugated PEG was tested using the integrated product peak areas in MALDI-TOF (matrix-assisted laser desorption/ionization-time-of-flight) mass spectrometry (Applied Biosystems 4800 Plus).
FTIR spectroscopy
The biocompatible GO/FA/PEG nanocarrier was characterized with a Bruker IFS 66 v/s infrared spectrometer (Bruker, Karlsruhe, Germany) by Fourier transform infrared (FT-IR) spectroscopy in the range 400-4000 cm -1 with a resolution of 4 cm -1 . The KBr pellet technique was adopted to prepare the samples for recording the IR spectra
TGA analysis
Thermogravimetric analysis (TGA) results were obtained with a TA Instrument 2050 thermogravimetric analyzer at a heating rate of 10℃ min-1 from 25 to 800℃ under a nitrogen atmosphere. The TGA curves of the functional graphene nanosheets were shown in Figure S2D . Thermogravimetric analysis (TGA) were used to characterize the thermal properties of GO-PEG-FA. For GO, a weight loss of 22 wt% at about 80℃ and 25 wt% at about 220℃ can be observed, which can be assigned to the loss of adsorbed water on GO and groups on GO such as hydroxyl and carboxylic groups, respectively. In the case of GO-PEG-FA, the initial degradation of 18% mass loss at about 180℃ may be due to the residual oxygen functional groups on GO, the formed amide groups between GO and PEG-FA and the decomposition of the FA. The weight loss of 23% GO-PEG-FA at around 400 ℃ is presumably assigned to the decomposition of the PEG in GO-PEG-FA. This also indicated that the PEG-FA was bound onto GO.
Gel retardation assay to access the quantity of siRNA delivered by PEGylated
GO-based nanocarriers
The siRNA binding ability of the PEGylated GO-based nanocarriers was studied by agarose gel electrophoresis [2] . GO/PEG/PAH (1 mg/mL) or GO/FA/PEG/PAH was mixed with siRNA (130 μg/mL) at five different mass ratios (GO:siRNA= 0. 
Flow Cytometry
For the flow cytometry of transfection efficiency experiments, Miapaca-2 cells were washed twice with phosphate-buffered saline (PBS) and harvested by trypsinization.
The FAM served as the luminescent marker (filter set for FITC was applied) and Cyc3 served as the luminescent marker (filter set for PE was applied) to determine the transfection efficiency quantitatively. The samples were analyzed using a FACS caliber flow cytometer (Becton Dickinson, Mississauga, CA). The transfection efficiency was calculated based on the reported methods (ref [2, 4] ) by calculating the number of cells in different gates.
Apoptosis assay
The apoptosis assay was conducted using an Annexin V: FITC Apoptosis Detection 
RNA isolation and quantitative RT-PCR
48 hours after transfection, total RNA was extracted from cells using TRIzol reagent (Invitrogen) and the amount of RNA was quantified by a spectrophotometer (Nano-Drop ND-2000). Total RNA (2 μg) was reverse transcribed to cDNA using the reverse transcriptase kit from Promega according to the manufacturer's instructions.
The mRNA levels of the target genes were quantified by real time PCR using SYBR green (Promega) in an ABI Prism 7500 real-time PCR system (Applied Biosystems).
Primers were shown in Table S2 .
Western Blotting
For western blot analysis, cells were seeded in 6-well plates and treated for 24 hours with GO-based nanocarriers as described for the RT-PCR assay. To isolate protein, cells were washed with PBS and harvested using the lysis buffer (50 mM Tris·Cl PH=6.8, 2% SDS, 6% Glycerol, 1% β-mercapitalethanol, 0.004% bromophenol blue).
Total cellular protein concentrations were determined by a spectrophotometer 
In vivo hemocompatibility
The protocol for in vivo hemocompatibility was based on previous literatures [5] . The general procedure was showed here: Fresh ethylenediamine tetraacetic acid (EDTA)-stabilized human whole blood samples were taken from animal center.
Typically, 5 mL of whole blood was added to 10 mL of calcium-and magnesium-free Dulbecco's phosphate buffered saline (PBS) and centrifuged at 500 g for 10 min to isolate RBCs from serum. This purification step was repeated three times, and then the washed RBCs were diluted to 50 mL in PBS. To test the hemolytic activity of GO/FA/SiRNA and GO/PEG/SiRNA samples, 0.1 mL of diluted RBC suspension (around 1 x 10 8 cells mL . No significant differences were found between the two groups.
In vivo imaging
When the tumor reached an appropriate volume of 200-300 mm 3 , the mice were injected with 200 μL of FA/GO/siRNA Cy3 (contained both K-Ras siRNA Cy3 and HDAC1 siRNA Cy3 , FA/GO 4mg/kg, siRNA 40μg=2.5 nmol, injection) by tail vein injection. After injection, mice were anesthetized with isoflurane. The induction concentration was 5% isoflurane/1L O2, and the maintenance concentration was 2-3% isoflurane/1L air. Once the mice were properly anesthetized, they were imaged at indicated time points to monitor the accumulation of FA/GO/siRNA Cy3 nanoparticles in tumors using the IVIS LuminaII small animal in vivo optical imaging system (Caliper).
In this study, the scanning wavelength range between 500 and 950 nm was used for in vivo imaging.
Preparation of paraffin section histological analysis (IHC)
For histological experiments, organ tissues were collected on the final day and fixed in 4% buffered formalin-saline at room temperature for 24 hours. Following this, tissues were embedded in paraffin blocks and paraffin sections of 4 mm thickness were mounted on a glass slide for hematoxylin and eosin (H&E) staining. The H&E staining slices were examined under a light microscopy (Olympus BX51).
For immunohistochemistry assay, pancreatic carcinoma tissue microarray slides were immersed in 3% H2O2 for 5 minutes to inactivate the endogenous peroxidase.
Nonspecific binding sites were blocked using 5% BSA for 15 minutes. Antibodies 
